ask="1.140000"
ask_size="1000"
average_daily_volume="107450"
bid="0.700000"
bid_size="200"
book_value="0.531000"
change="-0.029146"
change_from_200_day_moving_average="-0.469696"
change_from_50_day_moving_average="-0.252436"
change_from_52_week_high="-6.987146"
change_From_52_week_low="0.042654"
change_in_percent="-2.938100%"
close="0.962854"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.010000"
ebitda="-15.83M"
eps_estimate_current_year="-0.820000"
eps_estimate_next_quarter="-0.220000"
eps_estimate_next_year="-0.730000"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.000000"
high_52_weeks="7.950000"
last_trade_date="3/2/2017"
last_trade_price="0.962854"
last_trade_size="300"
last_trade_time="3:59pm"
low="0.950000"
low_52_weeks="0.920200"
market_capitalization="15.78M"
moving_average_200_day="1.432550"
moving_average_50_day="1.215290"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.000000"
open="0.980000"
pe_ratio="N/A"
peg_ratio="0.000000"
percent_change_from_200_day_moving_average="-32.787403%"
percent_change_from_50_day_moving_average="-20.771662%"
percent_change_from_52_week_high="-87.888634%"
percent_change_from_52_week_low="+4.635301%"
previous_close="0.992000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.868173"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.590000"
stock_exchange="NGM"
symbol="ORPN"
volume="83091"
weeks_range_52="0.920200 - 7.950000"
